Cargando…

P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES

Detalles Bibliográficos
Autores principales: Wijnen, Noa, Barneh, Farnaz, Meulendijks, Thomas, Klein, Kim, Duddebach, Ester, Cornel, Annelisa, Dautzenberg, Noël, Ashtiani, Minoo, Krippner-Heidenreich, Anja, Nierkens, Stefan, Heidenreich, Olaf, Kaspers, Gertjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429302/
http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5
_version_ 1785090677824028672
author Wijnen, Noa
Barneh, Farnaz
Meulendijks, Thomas
Klein, Kim
Duddebach, Ester
Cornel, Annelisa
Dautzenberg, Noël
Ashtiani, Minoo
Krippner-Heidenreich, Anja
Nierkens, Stefan
Heidenreich, Olaf
Kaspers, Gertjan
author_facet Wijnen, Noa
Barneh, Farnaz
Meulendijks, Thomas
Klein, Kim
Duddebach, Ester
Cornel, Annelisa
Dautzenberg, Noël
Ashtiani, Minoo
Krippner-Heidenreich, Anja
Nierkens, Stefan
Heidenreich, Olaf
Kaspers, Gertjan
author_sort Wijnen, Noa
collection PubMed
description
format Online
Article
Text
id pubmed-10429302
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104293022023-08-17 P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES Wijnen, Noa Barneh, Farnaz Meulendijks, Thomas Klein, Kim Duddebach, Ester Cornel, Annelisa Dautzenberg, Noël Ashtiani, Minoo Krippner-Heidenreich, Anja Nierkens, Stefan Heidenreich, Olaf Kaspers, Gertjan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429302/ http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Wijnen, Noa
Barneh, Farnaz
Meulendijks, Thomas
Klein, Kim
Duddebach, Ester
Cornel, Annelisa
Dautzenberg, Noël
Ashtiani, Minoo
Krippner-Heidenreich, Anja
Nierkens, Stefan
Heidenreich, Olaf
Kaspers, Gertjan
P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title_full P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title_fullStr P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title_full_unstemmed P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title_short P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
title_sort p437: effective immunotherapy of pediatric t(8;21) acute myeloid leukemia by repurposing cd3xcd19 targeting bispecific antibodies
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429302/
http://dx.doi.org/10.1097/01.HS9.0000968656.94193.a5
work_keys_str_mv AT wijnennoa p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT barnehfarnaz p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT meulendijksthomas p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT kleinkim p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT duddebachester p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT cornelannelisa p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT dautzenbergnoel p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT ashtianiminoo p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT krippnerheidenreichanja p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT nierkensstefan p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT heidenreicholaf p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies
AT kaspersgertjan p437effectiveimmunotherapyofpediatrict821acutemyeloidleukemiabyrepurposingcd3xcd19targetingbispecificantibodies